What is LOPJLB’s current signal on NSRX?

LOPJLB’s latest quantitative signal on Nasus Pharma Ltd. (NSRX) is BUY in a RECOVERY regime. Signals are updated daily.

What market regime is NSRX in?

Nasus Pharma Ltd. (NSRX) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Nasus Pharma Ltd. (NSRX) do?

Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats. The company's products include NS002, Intranasal Epinephrine for assisting in severe allergic reaction emergency situations and NS…

Where is Nasus Pharma Ltd. based / listed?

Nasus Pharma Ltd. is based in IL, listed on AMEX.

Nasus Pharma Ltd. (NSRX)

COMPARE

Healthcare · Medical - Pharmaceuticals · AMEX · IL

$3.78-1.56%Close

BUYRECOVERY · day 6

[SCORES & PROFILE]

FUND: 15
VALUE: 8
GROWTH: 47
GARP: 6
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-95.3%

REV YoY-

ROE-158.8%

EPS YoY-

ROA-87.8%

GROSS

NET

[VALUATION]

P/E TTM-3.69

P/E FWD-

SECTOR PE20.33

INDUSTRY PE106.69

P/B3.87

P/FCF-

EV/EBITDA-3.53

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E0.94

ALTMAN Z-

CURR RATIO8.77

ND/EBITDA-

BETA4.20

Nasus Pharma Ltd. (NSRX)

Key stats

Prediction markets

FUNDAMENTALS

Company news